- Home
- ACI vs ICLR Comparison
ACI vs ICLR Comparison
Compare ACI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACI
- ICLR
- Stock Information
- Founded
- ACI 1860
- ICLR 1990
- Country
- ACI United States
- ICLR Ireland
- Employees
- ACI N/A
- ICLR N/A
- Industry
- ACI Food Chains
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ACI Consumer Staples
- ICLR Health Care
- Exchange
- ACI Nasdaq
- ICLR Nasdaq
- Market Cap
- ACI 12.8B
- ICLR 11.4B
- IPO Year
- ACI 2020
- ICLR 1998
- Fundamental
- Price
- ACI $22.50
- ICLR $150.10
- Analyst Decision
- ACI Buy
- ICLR Buy
- Analyst Count
- ACI 12
- ICLR 12
- Target Price
- ACI $24.42
- ICLR $204.18
- AVG Volume (30 Days)
- ACI 5.0M
- ICLR 1.2M
- Earning Date
- ACI 07-15-2025
- ICLR 07-23-2025
- Dividend Yield
- ACI 2.74%
- ICLR N/A
- EPS Growth
- ACI N/A
- ICLR 11.53
- EPS
- ACI 1.64
- ICLR 9.19
- Revenue
- ACI $80,390,900,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- ACI $4.45
- ICLR N/A
- Revenue Next Year
- ACI $0.73
- ICLR $2.10
- P/E Ratio
- ACI $13.37
- ICLR $16.33
- Revenue Growth
- ACI 1.46
- ICLR N/A
- 52 Week Low
- ACI $17.00
- ICLR $125.10
- 52 Week High
- ACI $23.20
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- ACI 55.27
- ICLR 60.50
- Support Level
- ACI $21.06
- ICLR $142.89
- Resistance Level
- ACI $22.08
- ICLR $155.25
- Average True Range (ATR)
- ACI 0.40
- ICLR 4.79
- MACD
- ACI 0.07
- ICLR 0.51
- Stochastic Oscillator
- ACI 75.61
- ICLR 65.78
About ACI Albertsons Companies Inc.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.